Industries > Pharmaceutical and Life Sciences
PDF Stearns Weaver Miller's Pharmaceutical and Life Sciences Industry Group understands the business environment and unique challenges facing clients in these industry sectors. Our team includes attorneys with substantial in-house experience working for both pharmaceutical and medical device companies, and many others with years of experience providing counsel to these industry sectors.
The Firm has extensive experience in all aspects of pharmaceutical and life sciences litigation, including generic drug approval litigation and marketing exclusivity litigation under the Hatch-Waxman Act, intellectual property and drug development disputes between rival companies, disputes with raw material and other suppliers, product liability, counterfeiting, and a host of other pharmaceutical litigation matters. The Firm has won numerous cases in federal courts across the country against brand name pharmaceutical companies seeking to block generic drug approvals through patent and other litigation brought under the Hatch Waxman Act. We also have broad experience defending and prosecuting class actions, and particularly those involving antitrust or securities law violations in the pharmaceutical industry.
Our Firm's attorneys also have a wide range of experience representing pharmaceutical and medical device companies in corporate matters and commercial transactions. Our attorneys have extensive experience in mergers, acquisitions and sales of pharmaceutical and device companies, as well as in negotiating and documenting commercial transactions on behalf of medical technology companies including: supply, licensing, and distribution agreements with external suppliers and original equipment manufacturers; joint venture and strategic alliance agreements between our clients and other industry participants; and clinical trial, educational grant, consulting, and fellowship agreements between our clients and health care providers, research institutes and physicians. We also counsel clients on issues relating to health care compliance, anti-kick back regulations, pricing and contracting activities, and corporate compliance matters.
The Firm has extensive experience in all aspects of pharmaceutical and life sciences litigation, including generic drug approval litigation and marketing exclusivity litigation under the Hatch-Waxman Act, intellectual property and drug development disputes between rival companies, disputes with raw material and other suppliers, product liability, counterfeiting, and a host of other pharmaceutical litigation matters. The Firm has won numerous cases in federal courts across the country against brand name pharmaceutical companies seeking to block generic drug approvals through patent and other litigation brought under the Hatch Waxman Act. We also have broad experience defending and prosecuting class actions, and particularly those involving antitrust or securities law violations in the pharmaceutical industry.
Our Firm's attorneys also have a wide range of experience representing pharmaceutical and medical device companies in corporate matters and commercial transactions. Our attorneys have extensive experience in mergers, acquisitions and sales of pharmaceutical and device companies, as well as in negotiating and documenting commercial transactions on behalf of medical technology companies including: supply, licensing, and distribution agreements with external suppliers and original equipment manufacturers; joint venture and strategic alliance agreements between our clients and other industry participants; and clinical trial, educational grant, consulting, and fellowship agreements between our clients and health care providers, research institutes and physicians. We also counsel clients on issues relating to health care compliance, anti-kick back regulations, pricing and contracting activities, and corporate compliance matters.
Pharmaceutical and Life Sciences Attorneys
Alejandro M. Arrieta
Thomas G. Aubin
Zachary Scott Bower
Matthew W. Buttrick
Michael I. Keyes
Robert T. Kofman
Gordon McRae Mead, Jr.
Alison W. Miller
Samuel O. Patmore
Thomas J. Quarles
Paul R. Regensdorf
Glenn M. Rissman
Eric S. Roth
Adam M. Schachter
David M. Seifer
Jay B. Shapiro
Eric Solomon
Eugene E. Stearns
Martin B. Woods
Alejandro M. Arrieta
Thomas G. Aubin
Zachary Scott Bower
Matthew W. Buttrick
Michael I. Keyes
Robert T. Kofman
Gordon McRae Mead, Jr.
Alison W. Miller
Samuel O. Patmore
Thomas J. Quarles
Paul R. Regensdorf
Glenn M. Rissman
Eric S. Roth
Adam M. Schachter
David M. Seifer
Jay B. Shapiro
Eric Solomon
Eugene E. Stearns
Martin B. Woods